SureTrader Advertisement SureTrader
Home > Boards > Free Zone > All Trading - Technical > GoodFellas Big Board Catalyst and Chart Plays

GNOM - Research/DD summary & charts !

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
dDT  Member Profile
 
Followed By 470
Posts 76,651
Boards Moderated 3
Alias Born 03/31/08
160x600 placeholder
Shell Profit Falls But Beats Forecasts
Royal Dutch Shell unveiled its first set of earnings since its roughly $50 billion acquisition of BG Group earlier this year, reporting a sharp drop in first-quarter profit compared with a year earlier.
More Top Equities Stories Of The Day
Deutsche Bank North America CEO Jacques Brand to Leave for PJT Partners
Correction to Fitbit Jawbone Article on April 29
Ackman: No Plans to Sell Any Valeant `Crown Jewel' Assets -CNBC
Halliburton, Baker Strategies Differ -- WSJ
Brazilian Judge Lifts WhatsApp Ban -- Update
Abbott to Acquire St. Jude -- WSJ
Auto Sales Spring Ahead -- WSJ
Fiat Chrysler's U.S. Auto Sales Rise
dDT   Saturday, 01/07/12 08:05:22 AM
Re: dDT post# 1694
Post # of 83010 
GNOM - Research/DD summary & charts !

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.

Company's website: http://www.completegenomics.com/

Financial Reports: http://ir.completegenomics.com/financials.cfm

SEC filings: http://ir.completegenomics.com/sec.cfm

Nasdaq.com Stock Research - Analyst Summary

http://www.nasdaq.com/symbol/gnom/analyst-research


Contacts

Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788

GNOM Chart


SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist